Study of new drug for advanced prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new drug called JNJ-98768111 for people with advanced prostate cancer that has spread and no longer responds to standard hormone therapy. The drug may help shrink or slow the cancer, and participating could give you access to a promising new treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer that has spread to other parts of the body.
- You have tried at least one hormone therapy for prostate cancer (like abiraterone or enzalutamide).
- Your PSA level is at least 2 ng/mL.
- You are on ongoing hormonal therapy (medical castration) or have had surgery to lower testosterone.
- You are in a generally good health state (able to do most normal activities).
- You agree to use contraception and not father a child during and for 6 months after the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of two new investigational drugs for men with advanced prostate cancer that has spread and is no longer responding to hormone therapy. The drugs aim to help your immune system fight the cancer cells.
This trial tests a new combination of two study drugs for people with advanced prostate cancer that has spread or is no longer responding to hormone therapy. The goal is to see if the combination is safe and works against the cancer.
This trial tests a new combination of two drugs, pasritamig and JNJ-86974680, for men with a certain type of advanced prostate cancer that has spread to bone or lymph nodes but not to organs like the lungs or liver. It aims to see if this combination is safe and effective.
This trial tests an experimental new drug (GSK5471713) for men with advanced prostate cancer that has spread and stopped responding to hormone therapy. It is for people who have already tried certain hormone treatments and chemotherapy.
This trial tests a new investigational drug (JNJ-87890387) for people with certain advanced solid tumors that have spread or cannot be removed by surgery. It aims to see if the drug is safe and effective.
This trial tests a new drug called HLD-0915 in men with prostate cancer that has spread. It aims to see how well the drug works and if it's safe.
Hear when a new Prostatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.